Latest | F'cast | |
---|---|---|
Div Yield | 0.9% | |
Div Cover | 4.0 | |
Op Mrgn | 23.6% | |
ROCE | 33.1% |
Latest | F'cast | |
---|---|---|
P/E | 28.1 | |
PEG | 0.1 | |
Pr/Revenue | 5.3 | |
Pr/Book | 3.0 |
Latest | F'cast | |
---|---|---|
Revenue | 15.3% | |
PBT | 163.7% | |
EPS | 209.9% | |
DPS | 2.2% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 6,774.10 | 1,378.27 | 739.10¢ | 21.3 | 0.7 | +32% | 141.81¢ | 0.0% |
31-Dec-26 | 7,629.75 | 1,909.88 | 937.71¢ | 16.8 | 0.6 | +27% | 146.23¢ | 0.0% |
31-Dec-27 | 8,545.83 | 2,479.22 | 1,209.77¢ | 13.0 | 0.4 | +29% | 149.57¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Currency | Euro |
Share Price | 157.50 |
Change Today | -0.15 |
% Change | -0.10 % |
52 Week High | 196.80 |
52 Week Low | 129.35 |
Volume | 398,923 |
Shares Issued | 190.00m |
Market Cap | 29,925m |
Beta | 1.56 |
Strong Buy | 6 |
Buy | 8 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 0 |
Total | 20 |
Time | Volume / Share Price |
17:35 | 54 @ 157.50 |
17:35 | 57 @ 157.50 |
17:35 | 37 @ 157.50 |
17:35 | 26 @ 157.50 |
17:35 | 43 @ 157.50 |
You are here: research